Related Experiment Video
Updated: May 17, 2026

10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
Update in clinical allergy and immunology
S von Gunten1, B J Marsland, C von Garnier
1Institute of Pharmacology, University of Bern, Bern, Switzerland.
Allergy
|November 1, 2012
Summary
This review highlights recent advances in allergy and immunology, focusing on the microbiome's role in allergic diseases and novel therapeutic strategies. It aims to stimulate further research into current uncertainties and debates in the field.
Area of Science:
- Clinical Allergy and Immunology
- Microbiome Research
- Immunopathology
Background:
- Extensive research has explored diverse topics in clinical allergy and immunology.
- Recent studies offer clinically relevant insights and identify potential therapeutic targets.
- The microbiome's influence on allergic immune responses is a growing area of investigation.
Purpose of the Study:
- To review selected recent data in allergy and immunology.
- To discuss the role of the microbiome in allergic immune responses.
- To highlight novel therapeutic strategies and areas of scientific debate.
Main Methods:
- Literature review of recent studies in allergy and immunology.
- Focus on molecular and cellular mechanisms of allergic diseases.
- Examination of atopic dermatitis as a model for allergic disease.
Main Results:
- Recent data provide clinically and pathogenetically relevant insights.
- The microbiome plays a significant role in shaping allergic immune responses.
- Novel therapeutic targets and strategies are emerging.
Conclusions:
- The field of allergy and immunology is rapidly advancing.
- Understanding the microbiome is crucial for managing allergic diseases.
- Further research is needed to address current uncertainties and debates.
Related Concept Videos
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Allergic Reactions
Overview
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Cross-reactivity
Overview

